New treatment for advanced ovarian and lung cancer could give patients months longer to spend with their loved ones, early trial results suggest. Combination of targeted drug vistusertib and paclitaxel chemotherapy stopped growth of cancer for nearly 6 months and caused the tumours of some to shrink

See the source article by following the link below:
New treatment for advanced ovarian and lung cancer could give patients months longer to spend with their loved ones, early trial results suggest. Combination of targeted drug vistusertib and paclitaxel chemotherapy stopped growth of cancer for nearly 6 months and caused the tumours of some to shrink